In fact, the increase in RNF5 expression is associated with poor prognosis and survival of breast cancers [24] and hepatocellular carcinoma [46], and RNF5 degrades PTEN to promote pancreatic tumor growth [38]. The gene discussed is PTEN; the disease is breast carcinoma.